Rontis participated in ERA-EDTA 2017
Rontis participated in the 54th Nephrology Congress ERA – EDTA Madrid, Spain in June 3rd – 6th 2017.
Rontis was present for the second time in the specific marketing event. Our company participated in the congress as an exhibitor in order to introduce our extracorporeal blood circulation systems for hemodialysis treatment in the wider scientific and medical community.
EDTA was a great opportunity to demonstrate the wide range of Rontis Hemodialysis Blood Tubing sets, which are manufactured according to the most advanced international quality standards. We demonstrated our capability to meet the individual needs of current and potential customers via custom-made solutions. We placed Rontis in the radar screen of credible international suppliers of bloodlines. Furthermore, Rontis demonstrated its Cronus HP Peripheral Balloon, which is part of our Interventional Radiology product portfolio – this is a niche product for re-opening of AV fistulas in dialysis patients, which attracted many visitors.
Cronus HP is the first FDA approved product from Rontis portfolio and allowed our company to create new opportunities in the international expansion of our operations.
Rontis Corporation was represented by four company’s executives: Mrs. Efi Soultou (Rontis Corporation S.A. CFO/COO) Mr. Anastasios Politopoulos (VP, Int’l Business Development), Mr. George Makris (Intl’l Business Development Director, Medical Devices Division) and Mr. George Kakkos (Nephrology & Medical Disposables, Business Unit Manager, Rontis Hellas).